From: Radiomics analysis based on CT for the prediction of pulmonary metastases in ewing sarcoma
Train | Validation | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
AUC | ACC | 95%CI | Sensitivity | Specificity | AUC | ACC | 95%CI | Sensitivity | Specificity | ||
Pre-CT | |||||||||||
GP | 0.865 | 0.798 | 0.805–0.914 | 0.803 | 0.792 | 0.805 | 0.793 | 0.635–0.924 | 0.867 | 0.714 | |
LR | 0.842 | 0.781 | 0.779–0.895 | 0.754 | 0.811 | 0.800 | 0.689 | 0.635–0.913 | 0.667 | 0.714 | |
PLS-DA | 0.834 | 0.771 | 0.769–0.891 | 0.721 | 0.830 | 0.819 | 0.724 | 0.656–0.928 | 0.733 | 0.714 | |
CTE | |||||||||||
GP | 0.831 | 0.754 | 0.765–0.890 | 0.754 | 0.736 | 0.824 | 0.689 | 0.657–0.948 | 0.733 | 0.786 | |
LR | 0.834 | 0.789 | 0.761–0.891 | 0.787 | 0.792 | 0.833 | 0.759 | 0.678–0.944 | 0.800 | 0.714 | |
PLS-DA | 0.796 | 0.737 | 0.723–0.856 | 0.738 | 0.736 | 0.800 | 0.586 | 0.637–0.919 | 0.733 | 0.857 | |
ComB | |||||||||||
GP | 0.868 | 0.781 | 0.808–0.917 | 0.705 | 0.868 | 0.829 | 0.689 | 0.678–0.933 | 0.800 | 0.786 | |
LR | 0.866 | 0.798 | 0.807–0.913 | 0.852 | 0.736 | 0.852 | 0.724 | 0.709–0.956 | 0.800 | 0.857 | |
PLS-DA | 0.845 | 0.754 | 0.781–0.898 | 0.721 | 0.755 | 0.848 | 0.793 | 0.697–0.957 | 0.800 | 0.857 |